Intravenous the dose of esketamine ED95

DRUG2 trials

Sponsors

The First Affiliated Hospital of Xiamen University

Conditions

Hepatic CancerHepatic NeoplasmIntrauterine PolypIntrauterine Synechiae

Phase 1

Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia Care

Active, not recruitingNCT07034963

The First Affiliated Hospital of Xiamen UniversityIntrauterine Polyp, Intrauterine Synechiae

Start: 2025-06-26End: 2028-06-30Target: 95Updated: 2025-07-24

Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation

Active, not recruitingNCT07034950

The First Affiliated Hospital of Xiamen UniversityHepatic Cancer, Hepatic Neoplasm

Start: 2025-06-29End: 2028-06-30Target: 79Updated: 2025-09-11

Related Papers

Prospective Dose-Finding of Esketamine for Suppressing Cervical Dilation Response in Ambulatory Hysteroscopy Under Monitored Anesthesia Care.

2025-12-07